Recerca

Sarcomes i Histiocitosis

Buscador de publicacions

Publicacions

  • Reichardt P, Tabone MD, Mora J, Morland B and Jones RL.

    Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling

    FUTURE ONCOLOGY . 14(25): 2663-2676. Nº de cites: 108

    [doi:10.2217/fon-2018-0210]

  • Garcia-Monclus S, Lopez-Alemany R, Almacellas-Rabaiget O, Herrero-Martin D, Huertas-Martinez J, Lagares-Te L, Alba-Pavon P, Hontecillas-Prieto L, Mora J, de Alava E, Rello-Varona S, Giangrande PH and Tirado OM.

    EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma

    INTERNATIONAL JOURNAL OF CANCER . 143(5): 1188-1201. Nº de cites: 40

    [doi:10.1002/ijc.31405]

  • Pishas KI, Drenberg CD, Taslim C, Theisen ER, Johnson KM, Saund RS, Pop IL, Crompton BD, Lawlor ER, Tirode F, Mora J, Delattre O, Beckerle MC, Callen DF, Sharma S and Lessnick SL.

    Therapeutic Targeting of KDM1A/LSD1 in Ewing Sarcoma with SP-2509 Engages the Endoplasmic Reticulum Stress Response

    MOLECULAR CANCER THERAPEUTICS . 17(9): 1902-1916. Nº de cites: 43

    [doi:10.1158/1535-7163.MCT-18-0373]

  • Manzanares-Quintela A, Restrepo-Perdomo CA, Botteri G, Castillo H, Pascual-Pastó G, Cano F, Garcia-Alvarez L, Monterrubio C, Ruiz B, Vazquez M, Suñol M, Mora J, Tornero JA, Sosnik A and Carcaboso AM.

    Tissue Compatibility of SN-38-Loaded Anticancer Nanofiber Matrices

    ADVANCED HEALTHCARE MATERIALS . 7(15): . Nº de cites: 4

    [doi:10.1002/adhm.201800255]

  • Cavalli FMG, Hübner JM, Sharma T, Luu B, Sill M, Zapotocky M, Mack SC, Witt H, Lin T, Shih DJH, Ho B, Santi M, Emery L, Hukin J, Dunham C, McLendon RE, Lipp ES, Gururangan S, Grossbach A, French P, Kros JM, van Veelen MC, Rao AAN, Giannini C, Leary S, Jung S, Faria CC, Mora J, Schüller U, Alonso MM, Chan JA, Klekner A, Chambless LB, Hwang EI, Massimino M, Eberhart CG, Karajannis MA, Lu B, Liau LM, Zollo M, Ferrucci V, Carlotti C, Tirapelli DPC, Tabori U, Bouffet E, Ryzhova M, Ellison DW, Merchant TE, Gilbert MR, Armstrong TS, Korshunov A, Pfister SM, Taylor MD, Aldape K, Pajtler KW, Kool M and Ramaswamy V.

    Heterogeneity within the PF-EPN-B ependymoma subgroup

    ACTA NEUROPATHOLOGICA . 136(2): 227-237. Nº de cites: 86

    [doi:10.1007/s00401-018-1888-x]

  • Vinci M, Burford A, Molinari V, Kessler K, Popov S, Clarke M, Taylor KR, Pemberton HN, Lord CJ, Gutteridge A, Forshew T, Carvalho D, Marshall LV, Qin EY, Ingram WJ, Moore AS, Ng HK, Trabelsi S, H'mida-Ben Brahim D, Entz-Werle N, Zacharoulis S, Vaidya S, Mandeville HC, Bridges LR, Martin AJ, Al-Sarraj S, Chandler C, Suñol M, Mora J, de Torres C, Cruz-Martínez O, Carcaboso AM, Monje M, Mackay A and Jones C.

    Functional diversity and cooperativity between subclonal populations of pediatric glioblastoma and diffuse intrinsic pontine glioma cells

    NATURE MEDICINE . 24(8): 1204-1215. Nº de cites: 125

    [doi:10.1038/s41591-018-0086-7]

  • Vega-García N, Malatesta R, Estella-Aguado MC, Pérez-Jaume S, Esperanza-Cebollada E, Torrebadell-Burriel M, Català-Temprano A, Gassiot S, Berrueco R, Ruiz-Llobet A, Alonso-Saladrigues A, Mesegue-Meda M, Pont-Martí S, Rives-Solà S and Camós-Guijosa M.

    Paediatric patients with acute leukaemia and KMT2A (MLL) rearrangement show a distinctive expression pattern of histone deacetylases

    BRITISH JOURNAL OF HAEMATOLOGY . 182(4): 542-553. Nº de cites: 7

    [doi:10.1111/bjh.15436]

  • Koelsche C, Mynarek M, Schrimpf D, Bertero L, Serrano J, Sahm F, Reuss DE, Hou Y, Baumhoer D, Vokuhl C, Flucke U, Petersen I, Brück W, Rutkowski S, Zambrano SC, Garcia Leon JL, Diaz Coronado RY, Gessler M, Tirado OM, Mora J, Alonso J, Garcia Del Muro X, Esteller M, Sturm D, Ecker J, Milde T, Pfister SM, Korshunov A, Snuderl M, Mechtersheimer G, Schüller U, Jones DTW and von Deimling A.

    Primary intracranial spindle cell sarcoma with rhabdomyosarcoma-like features share a highly distinct methylation profile and DICER1 mutations

    ACTA NEUROPATHOLOGICA . 136(2): 327-337. Nº de cites: 100

    [doi:10.1007/s00401-018-1871-6]

  • Deng MY, Sill M, Chiang J, Schittenhelm J, Ebinger M, Schuhmann MU, Monoranu CM, Milde T, Wittmann A, Hartmann C, Sommer C, Paulus W, Gärtner J, Brück W, Rüdiger T, Leipold A, Jaunmuktane Z, Brandner S, Giangaspero F, Nozza P, Mora J, Morales-La Madrid A, Cruz-Martínez O, Hansford JR, Pietsch T, Tietze A, Hernáiz-Driever P, Stoler I, Capper D, Korshunov A, Ellison DW, von Deimling A, Pfister SM, Sahm F and Jones DTW.

    Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features

    ACTA NEUROPATHOLOGICA . 136(2): 239-253. Nº de cites: 111

    [doi:10.1007/s00401-018-1865-4]

  • Capper D, Engel NW, Stichel D, Lechner M, Glöss S, Schmid S, Koelsche C, Schrimpf D, Niesen J, Wefers AK, Jones DTW, Sill M, Weigert O, Ligon KL, Olar A, Koch A, Forster M, Moran S, Tirado OM, Sáinz-Japeado M, Mora J, Esteller M, Alonso J, Del Muro XG, Paulus W, Felsberg J, Reifenberger G, Glatzel M, Frank S, Monoranu CM, Lund VJ, von Deimling A, Pfister S, Buslei R, Ribbat-Idel J, Perner S, Gudziol V, Meinhardt M and Schüller U.

    DNA methylation-based reclassification of olfactory neuroblastoma

    ACTA NEUROPATHOLOGICA . 136(2): 255-271. Nº de cites: 53

    [doi:10.1007/s00401-018-1854-7]